Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Oral Oncol. 2013 Jul 23;49(9):893–902. doi: 10.1016/j.oraloncology.2013.06.011

Figure 1. Impact of vascular priming on drug delivery.

Figure 1

(A) Fluorescence microscopic images of subcutaneous FaDu tumors treated with Doxorubicin alone (Free Dox) or VDA (DMXAA 25 mg/kg, i.p.) in combination with Doxorubicin administration (VDA + Dox). (B) Bar graph shows quantification of fluorescent intensity levels from confocal microscopy images. A total of 14 fields were analyzed from 3 tumors per group (**p <0.01).